AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Non-opioid Pain Treatment Market Up to 2024 - Cancer, Epilepsy, Migraine & Multiple Sclerosis - ResearchAndMarkets.com

January 14, 2020 GMT

DUBLIN--(BUSINESS WIRE)--Jan 14, 2020--

The “Non-opioid Pain Treatment: Global Markets to 2024” report has been added to ResearchAndMarkets.com’s offering.

Report Scope:

This report is designed to be a helpful business tool that will provide a thorough evaluation of the markets for pain management. The geographical scope of this study is global. This study addresses acute versus chronic pain, treatments and regulatory issues facing healthcare workers. Also provided is detailed information based on product categories, use of products, forecasts and competitive analyses.

The report identifies five general product segments for Non-opioid treatment of pain

Within the segment several sub-segments are discussed as they pertain to each product segment; diseases or disorders are the basis for these sub-segments, including

A regional analysis of these product segments is also provided, including the specific countries listed below and including countries not listed as a rest of the world market

The Report Includes:

Key Topics Covered:

Chapter 1 Introduction

Chapter 2 Summary and Highlights

Chapter 3 Market Overview and Background

Chapter 4 Market Breakdown by Product Segment

Chapter 5 Market Breakdown by Therapeutic Application

Chapter 6 Market Breakdown by Region

Chapter 7 Patent Analysis

Chapter 8 Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/e85sck

View source version on businesswire.com:https://www.businesswire.com/news/home/20200114005454/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2020.

PUB: 01/14/2020 08:12 AM/DISC: 01/14/2020 08:12 AM

http://www.businesswire.com/news/home/20200114005454/en